These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

272 related items for PubMed ID: 21921333

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Peripheral nerve sheath tumor: differentiation of malignant from benign tumors with conventional and diffusion-weighted MRI.
    Yun JS, Lee MH, Lee SM, Lee JS, Kim HJ, Lee SJ, Chung HW, Lee SH, Shin MJ.
    Eur Radiol; 2021 Mar; 31(3):1548-1557. PubMed ID: 32894357
    [Abstract] [Full Text] [Related]

  • 3. Multimodal Imaging in Neurofibromatosis Type 1-associated Nerve Sheath Tumors.
    Salamon J, Mautner VF, Adam G, Derlin T.
    Rofo; 2015 Dec; 187(12):1084-92. PubMed ID: 26333104
    [Abstract] [Full Text] [Related]

  • 4. Imaging cellularity in benign and malignant peripheral nerve sheath tumors: Utility of the "target sign" by diffusion weighted imaging.
    Ahlawat S, Fayad LM.
    Eur J Radiol; 2018 May; 102():195-201. PubMed ID: 29685535
    [Abstract] [Full Text] [Related]

  • 5. Evaluation of magnetic resonance imaging-based radiomics characteristics for differentiation of benign and malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ristow I, Madesta F, Well L, Shenas F, Wright F, Molwitz I, Farschtschi S, Bannas P, Adam G, Mautner VF, Werner R, Salamon J.
    Neuro Oncol; 2022 Oct 03; 24(10):1790-1798. PubMed ID: 35426432
    [Abstract] [Full Text] [Related]

  • 6. Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI.
    Matsumine A, Kusuzaki K, Nakamura T, Nakazora S, Niimi R, Matsubara T, Uchida K, Murata T, Kudawara I, Ueda T, Naka N, Araki N, Maeda M, Uchida A.
    J Cancer Res Clin Oncol; 2009 Jul 03; 135(7):891-900. PubMed ID: 19101731
    [Abstract] [Full Text] [Related]

  • 7. Evaluation of (18)F-FDG PET and MRI in differentiating benign and malignant peripheral nerve sheath tumors.
    Broski SM, Johnson GB, Howe BM, Nathan MA, Wenger DE, Spinner RJ, Amrami KK.
    Skeletal Radiol; 2016 Aug 03; 45(8):1097-105. PubMed ID: 27115884
    [Abstract] [Full Text] [Related]

  • 8. MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas.
    Wasa J, Nishida Y, Tsukushi S, Shido Y, Sugiura H, Nakashima H, Ishiguro N.
    AJR Am J Roentgenol; 2010 Jun 03; 194(6):1568-74. PubMed ID: 20489098
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Discrimination of benign, atypical, and malignant peripheral nerve sheath tumors in neurofibromatosis type 1 using diffusion-weighted MRI.
    Ristow I, Kaul MG, Stark M, Zapf A, Riedel C, Lenz A, Mautner VF, Farschtschi S, Apostolova I, Adam G, Bannas P, Salamon J, Well L.
    Neurooncol Adv; 2024 Jun 03; 6(1):vdae021. PubMed ID: 38468867
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Association between benign and malignant peripheral nerve sheath tumors in NF1.
    Tucker T, Wolkenstein P, Revuz J, Zeller J, Friedman JM.
    Neurology; 2005 Jul 26; 65(2):205-11. PubMed ID: 16043787
    [Abstract] [Full Text] [Related]

  • 13. Patterns of recurrence and survival in sporadic, neurofibromatosis Type 1-associated, and radiation-associated malignant peripheral nerve sheath tumors.
    Watson KL, Al Sannaa GA, Kivlin CM, Ingram DR, Landers SM, Roland CL, Cormier JN, Hunt KK, Feig BW, Ashleigh Guadagnolo B, Bishop AJ, Wang WL, Slopis JM, McCutcheon IE, Lazar AJ, Torres KE.
    J Neurosurg; 2017 Jan 26; 126(1):319-329. PubMed ID: 27035165
    [Abstract] [Full Text] [Related]

  • 14. Malignant peripheral nerve sheath tumors (MPNST) in neurofibromatosis type 1 (NF1): diagnostic findings on magnetic resonance images and mutation analysis of the NF1 gene.
    Friedrich RE, Kluwe L, Fünsterer C, Mautner VF.
    Anticancer Res; 2005 Jan 26; 25(3A):1699-702. PubMed ID: 16033085
    [Abstract] [Full Text] [Related]

  • 15. Imaging biomarkers for malignant peripheral nerve sheath tumors in neurofibromatosis type 1.
    Ahlawat S, Blakeley JO, Rodriguez FJ, Fayad LM.
    Neurology; 2019 Sep 10; 93(11):e1076-e1084. PubMed ID: 31395668
    [Abstract] [Full Text] [Related]

  • 16. Diagnostic Quality of Magnetic Resonance Imaging Interpretation for Peripheral Nerve Sheath Tumors: Can Malignancy Be Determined?
    Karsy M, Guan J, Ravindra VM, Stilwill S, Mahan MA.
    J Neurol Surg A Cent Eur Neurosurg; 2016 Nov 10; 77(6):495-504. PubMed ID: 27276118
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Malignant and Benign Peripheral Nerve Sheath Tumors in a Single Center: Value of Clinical and Ultrasound Features for the Diagnosis of Malignant Peripheral Nerve Sheath Tumor Compared With Magnetic Resonance Imaging.
    Jin Z, Wang C, Wang D, Li X, Guo W, Chen T.
    J Ultrasound Med; 2024 Jan 10; 43(1):21-31. PubMed ID: 37772628
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. 18F-FDG PET/CT qualitative and quantitative evaluation in neurofibromatosis type 1 patients for detection of malignant transformation: comparison of early to delayed imaging with and without liver activity normalization.
    Chirindel A, Chaudhry M, Blakeley JO, Wahl R.
    J Nucl Med; 2015 Mar 10; 56(3):379-85. PubMed ID: 25655626
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.